Brief: Vallon Pharmaceuticals Reports Qtrly Net Loss Of $1.3 Mln

GRI Bio

12/11/2021 13:15

Nov 12 (Reuters) - Vallon Pharmaceuticals Inc  VLON.O :
    * VALLON PHARMACEUTICALS REPORTS THIRD QUARTER 2021
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * VALLON PHARMACEUTICALS INC - NET LOSS FOR QUARTER ENDED
SEPTEMBER 30, 2021, WAS $1.3 MILLION
    * VALLON PHARMACEUTICALS - EXPECTS CASH, CASH EQUIVALENTS
WILL
PROVIDE FUNDING FOR ITS ONGOING DEVELOPMENT AND BUSINESS
ACTIVITIES INTO Q3 OF 2022.

Source text for Eikon:  ID:nGNX7kTTKL 
Further company coverage:  VLON.O 

 ((Reuters.Briefs@thomsonreuters.com;))